Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03602365 · ClinicalTrials.gov registry record · NA

Gentle Jogger and Oxygen Consumption

A NA study of Physical Inactivity and Oxygen Consumption, sponsored by Sackner Wellness Products.

Completed
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT03602365 is a NA study of Physical Inactivity and Oxygen Consumption that has completed, run by Sackner Wellness Products. The registered enrollment target is 24 participants, below the 225-participant average among 59 other Physical Inactivity trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03602365, a NA study of Physical Inactivity and Oxygen Consumption, has completed, sponsored by Sackner Wellness Products.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

This is a non randomized study to determine the effects of Gentle Jogger(GJ), a passive jogging device on oxygen consumption in 2 postures supine and seated. Oxygen consumption measurements will be performed via indirect calorimetry in duplicate at rest ( supine and seated posture) , and repeated in duplicate during GJ (in supine and seated posture)

Interventions

  • DEVICE Gentle Jogger (GJ)

Study Locations (1)

Florida

  • CIC Miami - Miami

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2018-06-01
Est. Completion 2020-01-23
Phase NA

Sponsor

Sackner Wellness Products

3 total trials

What the Registry Record Tells You About NCT03602365

The ClinicalTrials.gov registry entry for NCT03602365 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 225-participant average among 59 other Physical Inactivity trials with a reported enrollment target (89% lower). The listed sponsor is Sackner Wellness Products, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Physical Inactivity appearing as the primary indexed condition, and to 1 intervention - of which Gentle Jogger (GJ) is the first listed.

NCT03602365 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT03602365 about?

NCT03602365 is a clinical study titled "Gentle Jogger and Oxygen Consumption". This is a non randomized study to determine the effects of Gentle Jogger(GJ), a passive jogging device on oxygen consumption in 2 postures supine and seated. Oxygen consumption measurements will be performed via indirect calorimetry in duplicate at rest ( supine and seated posture) , and repeated in...

What is the current status of trial NCT03602365?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2018-06-01. Estimated completion is 2020-01-23.

What conditions does trial NCT03602365 study?

This clinical trial studies the following conditions: Physical Inactivity, Oxygen Consumption.

What interventions are being tested in trial NCT03602365?

The interventions under investigation include: Gentle Jogger (GJ) (DEVICE).

Who is sponsoring clinical trial NCT03602365?

This trial is sponsored by Sackner Wellness Products, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03602365 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Physical Inactivity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.